Search
Caribou Biosciences Inc
CRBUAdd to Watchlist
1.265USD
-0.025-1.94%
Market hours 09/24, 13:08（ET）
125.46MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-1.94%
5 Days
+1.20%
1 Month
-23.80%
6 Months
-31.99%
Year to Date
-20.44%
1 Year
-31.99%
Key Figures
1.288Open
1.360High
56.59KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.06%Turnover Ratio
1.290Prev. Close
1.250Low
71.48KTurnover
LossP/E Static
1.28P/B
0.00%Div Yield TTM
-63.04%ROA
3.53552wk High
0.09Volume Ratio
-149.10MNet Profit
99.18MShares
-1.4163EPS TTM
2.32Beta
-83.46%ROE
1.25052wk Low
8.53%Amplitude
100.00%Gross Margin
125.46MMarket Cap
-0.51Reward/Risk
4.43%Risk Rate
More news coming soon, stay tuned...
Caribou Biosciences Inc's Score
-0.05vs previous score
Forecast8.86
Financial Health5.79
Technical4.79
Valuation Dimensions6.98
Institutional Confidence3.00
Risk Assessment4.35
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Caribou Biosciences Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.24/-0.32
Revenue / Forecast
1.50M/2.28M
Caribou Biosciences Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolCRBU
Number of employees147
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Pfizer Inc | 4.73% |
| Vanguard Capital Management, LLC | 3.80% |
| Haurwitz (Rachel E. Ph.D.) | 3.53% |
| Kynam Capital Management LP | 2.52% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 16.30% |
| Hedge Fund | 10.81% |
| Investment Advisor/Hedge Fund | 6.18% |
| Corporation | 4.73% |
Related Instruments
+3.09%
+0.54%
-0.55%
+0.38%
+0.69%
+1.48%
-0.38%
-0.40%
+0.64%
+1.06%
+0.89%
-0.70%
-0.20%
+0.10%
-1.51%
-1.33%
+0.92%
+0.72%
-1.22%
+1.46%Popular Instruments
51371.900
-118.100 (-0.23%)
30489.300
+11.400 (+0.04%)
7709.300
+2.300 (+0.03%)
14280.000
-142.000 (-0.98%)
65948.000
-181.000 (-0.27%)
6316.200
+26.200 (+0.42%)
94.143
+1.653 (+1.79%)
337.960
+0.940 (+0.28%)
224.290
-1.220 (-0.54%)
4269.540
-16.700 (-0.39%)
FAQs
What is the current price of Caribou Biosciences Inc (CRBU)?
The current price of Caribou Biosciences Inc (CRBU) is 1.29.
What is the symbol of Caribou Biosciences Inc?
The ticker symbol of Caribou Biosciences Inc is CRBU.
What is the 52-week high of Caribou Biosciences Inc?
The 52-week high of Caribou Biosciences Inc is 3.54.
What is the 52-week low of Caribou Biosciences Inc?
The 52-week low of Caribou Biosciences Inc is 1.25.
What is the market capitalization of Caribou Biosciences Inc?
The market capitalization of Caribou Biosciences Inc is 127.94M.
Is Caribou Biosciences Inc (CRBU) currently rated as Buy, Hold, or Sell?
According to analysts, Caribou Biosciences Inc (CRBU) has an overall rating of Buy, with a price target of 11.86.
What is the Earnings Per Share (EPS TTM) of Caribou Biosciences Inc (CRBU)?
The Earnings Per Share (EPS TTM) of Caribou Biosciences Inc (CRBU) is -1.42.